Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020784
Filing Date
2025-07-31
Accepted
2025-07-31 18:52:43
Documents
1
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 form4-07312025_100740.html 4  
1 form4-07312025_100740.xml 4 4019
  Complete submission text file 0001415889-25-020784.txt   5468
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MORPHIMMUNE INC. 101 FOUNDRY DRIVE, SUITE 1200 WEST LAFAYETTE IN 47906
Business Address
Higgins Jack (Reporting) CIK: 0001993684 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 251173238